FDA Adverse Event Malfunction Summary report: N

BARRICAID ACD

MDR report key: 15052339 · Received July 19, 2022

Report

Report Number
3006232063-2022-00001
Event Type
Malfunction
Date Received
July 19, 2022
Date of Event
January 5, 2022
Report Date
July 18, 2022
Manufacturer
INTRINSIC THERAPEUTICS, INC.
Product Code
QES
PMA / PMN Number
P160050
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

PATIENT HAD AN INITIAL IMPLANT OF THE BARRICAID ON (B)(6) 2019. THE PATIENT STARTED EXPERIENCING PAIN ON (B)(6) 2021. RE-OPERATION OCCURRED ON (B)(6) 2022. DURING SURGERY, A PROLAPSE WAS SEEN MEDIAL TO THE POLY MESH OF THE IMPLANT. THE MESH FLIPPED DORSALLY AND PARTIALLY FUSED TO THE DURA/ROOT. ISOLATED EXTRACTION OF THE MESH WAS NOT POSSIBLE. THE ANCHOR REMAINED IN THE VERTEBRAL BODY BECAUSE IT WAS FIRMLY ANCHORED IN THE BONE. AFTER PERFORMANCE OF THE SEQUESTROTOMY THE WOUND WAS CLOSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
251497 BARRICAID ACD BARRICAID QES INTRINSIC THERAPEUTICS, INC. BAR-D8-12X14 12041803

Patients

Seq Age Sex Outcome Treatment
1 53 YR Female Required Intervention